文献速递类风湿关节炎

类风湿关节炎患者在治疗选择中可接受何种获益-风险权衡:来自多国选择实验的证据

What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.
PubMed 文献 · RMD Open · 2024-01-09

该研究通过在线离散选择实验评估类风湿关节炎(RA)患者在选择治疗时愿意做出的权衡。2090名来自欧洲或美国的RA患者完成了选择任务,所有治疗属性的估计效应均显著(p<0.001),但患者间存在差异;减少疼痛和精液参数负面影响对男性最重要,而女性最关注血栓和严重感染风险。没有单一属性解释治疗偏好超过30%,患者愿意以更高的严重感染和血栓风险换取疼痛、日常活动或给药便利性的改善,但可接受的权衡因患者而异(p<0.05)。

要点

  • 减少疼痛和精液参数负面影响对男性最重要,女性最关注血栓和严重感染风险。
  • 没有单一属性解释治疗偏好超过30%,患者愿意以更高严重感染和血栓风险换取获益改善。
  • 可接受的获益-风险权衡因患者而异(p<0.05)。

核心结论

  • RA患者的治疗偏好具有个体特异性,但由获益和风险驱动,没有单一属性主导决策。

研究设计与样本

  • 研究为在线离散选择实验,纳入≥18岁、确诊RA、正在接受系统性改善病情抗风湿药治疗且居住在欧洲或美国的患者,男性被过度抽样以进行亚组分析,数据采用相关混合logit模型分析。

主要发现

  • 共2090名参与者,42%为女性,平均年龄45.2岁(范围18-83)。
  • 所有治疗属性的估计效应均显著(p<0.001),但在患者间存在差异。
  • 平均相对属性重要性评分显示男性和女性之间的优先级不同(p<0.001)。
  • 减少疼痛和精液参数负面影响对男性最重要,而女性最关注血栓和严重感染风险。
  • 没有单一属性解释治疗偏好超过30%;18-44岁患者对给药频率和给药方式的重视程度低于较年长组(p<0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Understanding preferences of patients with rheumatoid arthritis (RA) can facilitate tailored patient-centric care. This study elicited trade-offs that patients with RA were willing to make during treatment selection. METHODS: Patients with RA completed an online discrete choice experiment, consisting of a series of choices between hypothetical treatments. Treatment attributes were selected based on literature review and qualitative patient interviews. Eligible patients were ≥18 years old, diagnosed with RA, receiving systemic disease-modifying antirheumatic drug therapy, and residents of Europe or USA. Male patients were oversampled for subgroup analyses. Data were analysed using a correlated mixed logit model. RESULTS: Of 2090 participants, 42% were female; mean age was 45.2 years (range 18-83). Estimated effects were significant for all attributes (p<0.001) but varied between patients. Average relative attribute importance scores revealed different priorities (p<0.001) between males and females. While reducing pain and negative effect on semen parameters was most important to males, females were most concerned by risk of blood clots and serious infections. No single attribute explained treatment preferences by more than 30%. Preferences were also affected by patients' age: patients aged 18-44 years placed less importance on frequency and mode of treatment administration (p<0.05) than older age groups. Patients were willing to accept higher risk of serious infections and blood clots in exchange for improvements in pain, daily activities or administration convenience. However, acceptable trade-offs varied between patients (p<0.05). CONCLUSION: Treatment preferences of patients with RA were individual-specific, but driven by benefits and risks, with no single attribute dominating the decision-making.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Alten R, Nieto-Gonzalez JC, Jacques P, et al. What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment. RMD Open. 2024. PMID: 38199605. doi:10.1136/rmdopen-2023-003311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。